S&P 500 Industrials Sector SEC Filings — March 25, 2026

25-03-2026

ECB Bancorp reported strong improvements in asset quality with non-performing assets declining 42% to $1,139 thousand (0.07% of total assets) at December 31, 2025 from $1,957 thousand (0.14%), and net interest income surging 29% to $31,160 thousand driven by 14% loan growth to average $1,263M and higher yields (5.47% vs 5.24%). Noninterest income rose 8.2% to $1,326 thousand. However, noninterest expenses increased 3.2% to $21,330 thousand, with notable rises in FDIC deposit insurance (+17.4%) and advertising (+16.0%), while some items like director compensation declined 4.4%.

• ·Non-accrual one-to-four family residential loans declined to $1,096 thousand from $1,872 thousand at Dec 31.
• ·Home equity lines non-accrual declined to $43 thousand from $85 thousand at Dec 31.
• ·Income from bank-owned life insurance nearly flat at $475 thousand vs $473 thousand (+0.4%).
• ·Computer software and licensing fees slightly declined 0.5% to $441 thousand.
• ·Short-term investments yield declined to 4.33% from 5.25%.
• ·Savings accounts interest rate declined to 2.03% from 2.72%.
• ·Money market accounts interest rate declined to 3.30% from 3.58%.
• ·Certificates of deposit interest rate declined to 4.15% from 4.34%.

25-03-2026

Fresh Del Monte Produce Inc. (NYSE: FDP) completed the acquisition of select assets from Del Monte Foods Corporation II Inc. for approximately $285 million, reuniting the Del Monte® brand under one owner for the first time in nearly four decades and expanding its prepared and packaged foods platform. The transaction includes global ownership of the Del Monte® brand (subject to existing licenses), brands such as S&W®, Contadina®, and packaged vegetables/tomatoes/refrigerated fruits, plus manufacturing facilities in the US, Mexico, and Venezuela. While expected to enhance brand consistency, efficiency, and growth, forward-looking statements note integration risks including operational disruptions and additional indebtedness.

• ·Acquisition approved by U.S. Bankruptcy Court for the District of New Jersey under Section 363 of the U.S. Bankruptcy Code.
• ·Funded via cash on hand and revolving credit facility availability.
• ·Excludes canned fruit and ambient packaged fruit/fruit sauce products for U.S., Puerto Rico, Mexico; physical assets for those businesses.
• ·Dedicated business unit for acquired brands/businesses to ensure operational continuity; no immediate changes to products, packaging, or distribution.
• ·Rabobank (financial advisor), Greenberg Traurig and Dickinson Wright (legal advisors) to Fresh Del Monte.
• ·Integration progress and financial expectations to be shared in Q1 2026 earnings call.

25-03-2026

Amneal Pharmaceuticals, Inc. (AMRX) issued its 2026 Proxy Statement for the annual stockholder meeting on May 6, 2026, seeking votes to elect 10 director nominees, approve named executive officer compensation on an advisory basis, and ratify Ernst & Young LLP as independent auditors for fiscal 2026. The accompanying letter from Co-CEOs Chintu Patel and Chirag Patel highlights 2025 achievements, including 8% YoY revenue growth driven by strong Specialty (+double-digit) and Affordable Medicines segments, CREXONT® uptake reaching approximately 22,000 patients, multiple product launches and approvals, and debt refinancing to extend maturities to 2032; no declines or flat performances were noted. The company underscores its diversified portfolio of over 290 marketed products, 110+ pipeline programs, and strategy across Specialty, Affordable Medicines (including biosimilars), and AvKARE.

• ·Record date: March 12, 2026
• ·Annual meeting: May 6, 2026 at 9:00 a.m. EDT, virtual at www.virtualshareholdermeeting.com/AMRX2026
• ·Fiscal year end: December 31
• ·Debt maturities extended from 2028 to 2032 via refinancing

25-03-2026

Artificial Intelligence Technology Solutions, Inc. (AITX) filed a Form 8-K on March 25, 2026, under Items 8.01 and 9.01, announcing the issuance of a press release titled 'AITX's RAD Inks Continued Expansion Orders from Global Logistics Leader.' The press release, attached as Exhibit 99.1, highlights ongoing business expansion with a major client, signaling positive momentum in RAD deployments.

• ·Filed with SEC on March 25, 2026; Date of earliest event: March 25, 2026
• ·Registrant details: Nevada incorporation, CIK 0001498148, EIN 27-2343603, principal offices at 10800 Galaxie Avenue, Ferndale, Michigan 48220
• ·Information furnished under Item 8.01, not deemed 'filed' or subject to Section 18 liabilities

25-03-2026

Nuveen Global Cities REIT, Inc. filed Amendment No. 1 to its Form 10-K for the fiscal year ended December 31, 2025, solely to insert omitted conformed signatures of the company and its board of directors from the original filing on March 20, 2026. As of March 20, 2026, the company reported outstanding shares across classes: Class T (11,729,524), Class S (47,894,924), Class D (7,405,823), Class I (113,292,244), and Class N (23,454,145), totaling approximately 203.8 million shares. No financial results, performance metrics, or other substantive changes are included or revised.

• ·Principal executive offices: 730 Third Avenue, 3rd Floor, New York, NY 10017
• ·Commission File Number: 000-56273
• ·I.R.S. Employer Identification No.: 82-1419222
• ·Registrant is a non-accelerated filer and not a well-known seasoned issuer, smaller reporting company, or emerging growth company

25-03-2026

Talphera, Inc. (TLPH) filed a Form S-3 registration statement on March 24, 2026, to enable the resale by selling stockholders of up to 639,931 shares of common stock and 6,399,316 shares issuable upon exercise of pre-funded warrants from the Third Closing of its 2025 Private Placement on March 31, 2025, which generated approximately $4.1M in gross proceeds. The company will not receive any proceeds from these resales and bears the registration costs. No current financial performance metrics or period-over-period comparisons are disclosed in the filing.

• ·Purchase price: $0.586 per common share and $0.585 per pre-funded warrant
• ·Pre-funded warrants exercise price: $0.001 per share with unlimited term
• ·Last reported sale price of common stock on March 23, 2026: $0.8012 per share
• ·Company classified as smaller reporting company and non-accelerated filer

25-03-2026

Pasqal Holding SAS, the target in the proposed business combination with Bleichroeder Acquisition Corp. II, plans a Nasdaq listing in 2026 followed by a secondary Euronext listing, highlighting its neutral-atom quantum computers with ~200 qubits, a 2024 1,000-qubit demonstration, and manufacturing lead times reduced to 9-12 months from over two years. The company signed an MOU with Seoul Metropolitan Government for a quantum R&D center involving $52.84M investment and 51 new jobs, while expanding partnerships with LG Electronics, BMW, EDF, Thales, and Crédit Agricole CIB. Pasqal aims to scale to 10,000-qubit systems using Photonic Integrated Circuits and positions itself as a leader with a workforce of over 275 employees, including ~70 PhDs.

• ·Pasqal founded in 2019 at Institut d’Optique, France; first commercialized 200-qubit quantum computer.
• ·Quantum computers delivered to GENCI (France, 2024), Aramco (Saudi Arabia, 2025), and installed in Italy, Canada, Germany.
• ·Three of eight EuroHPC JU commissioned quantum computers are Pasqal models.
• ·Manufacturing facility expanded with nine QPU bays; additional production site in Canada.
• ·Operates at room temperature (~20°C) using laser-based neutral-atom control, no cryogenic cooling required.

25-03-2026

Range Capital Acquisition Corp II (RNGTW), a SPAC, reported total assets of $233.4M as of December 31, 2025, with $232.1M held in the Trust Account from 23M Class A ordinary shares at $10.09 redemption value. For the period from inception (May 22, 2025) through year-end, the company posted net income of $1.8M driven by $2.1M interest income, but incurred an operating loss of $0.3M from G&A expenses, resulting in a shareholders' deficit of $6.9M.

• ·Cash balance: $1.1M; Prepaid expenses: $85K; Long-term prepaid insurance: $53K
• ·Accounts payable and accrued expenses: $11K; Accrued offering costs: $75K
• ·Basic and diluted EPS for Class A and B shares: $0.12
• ·Possible working capital loans up to $1.5M convertible into units at $10.00 per unit

25-03-2026

Pure Storage, Inc. reported total revenue of $3.66B for FY2026, up 16% YoY from $3.17B in FY2025, driven by 16% growth in product revenue to $1.97B and 15% in subscription services revenue to $1.69B; subscription ARR also grew 16% YoY to $1.92B. However, operating expenses increased notably with R&D up 20% to $725M, sales and marketing up 17% to $1.08B, and total cost of revenue up 14% to $1.08B, while gross margins remained flat at 70%. Net cash from operating activities improved to $880M, though financing cash use deepened.

• ·Product gross margin improved slightly to 67% from 66% YoY.
• ·Subscription services gross margin flat at 74% YoY.
• ·G&A expenses increased 10% YoY to $229M.
• ·Net cash used in investing activities improved to $(108M) from $(218M).
• ·Net cash used in financing activities increased to $(645M) from $(510M).

25-03-2026

Range Capital Acquisition Corp. reported net income of $4.0M for the year ended December 31, 2025, a turnaround from a $39K loss in the period from inception (July 24, 2024) through December 31, 2024, primarily driven by $4.8M in interest earned on the Trust Account. However, operating costs increased significantly to $803K from $147K over the comparable periods, resulting in a larger operating loss. The Trust Account balance grew to $120.5M as of December 31, 2025, from $100.6M a year earlier, with redemption value rising to $10.48 per share.

• ·Up to $1.5M in non-interest bearing loans from initial shareholders, officers, or directors may be convertible into working capital units at $10.00 per unit.
• ·Shareholders’ equity decreased to $211K as of Dec 31, 2025 from $847K as of Dec 31, 2024.
• ·Over-allotment option liability settled to $0 from $148K.

25-03-2026

Aldel Financial II Inc., a blank check company (SPAC), filed its 10-K for the year ended December 31, 2025, reporting no principal operations and a trust account balance of $243.0M (approximately $10.57 per public share), up from $231.2M initially funded post-IPO due to interest income. The company raised $230.0M gross proceeds from its October 23, 2024 IPO of 23.0M units at $10.00 each (including over-allotment) and $7.1M from private placements, while holding $0.5M cash outside the trust. It continues seeking a business combination in financial services within a 24-month window, with no redemptions or withdrawals from trust for taxes to date.

• ·IPO registration statement effective Oct 21, 2024; Public Warrants exercisable at $11.50/share after BC or 12 months post-IPO.
• ·24-month period to complete initial Business Combination (from Oct 23, 2024).
• ·No interest withdrawn from trust for taxes as of Dec 31, 2025.
• ·Sponsor transferred 690,000 founder shares to management and board on Aug 13, 2024.

25-03-2026

Rogers Corporation filed Definitive Additional Proxy Materials (DEFA14A) on March 25, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing indicates no fee was required and is marked as Definitive Additional Materials, not preliminary or soliciting material under specific rules. No substantive financial data, metrics, or changes are disclosed in the provided filing header.

• ·Filing Type: DEFA14A (Definitive Additional Materials)
• ·Filed by the Registrant
• ·No fee required

25-03-2026

Brand Engagement Network Inc. announced that Bernard Puckett notified the Board he will step down as Chairman and resign as a director effective March 31, 2026, after serving as Interim Chairman since August 2025 and Board member since April 2023; his departure is not due to any disagreements. The Board appointed independent director Jon Leibowitz as the new Chairman effective April 1, 2026. Mr. Leibowitz brings extensive experience from roles at the Federal Trade Commission, Davis Polk & Wardwell LLP, and as Chairman of the National Consumers League.

• ·Puckett served as Chair of the Audit Committee and member of Compensation Committee and Nominating and Corporate Governance Committee.
• ·Leibowitz currently serves as Chair of the Nominating and Corporate Governance Committee and member of the Audit Committee.
• ·Resignation letter from Puckett dated March 20, 2026, attached as Exhibit 17.1.

25-03-2026

The Chiba Kogyo Bank, Ltd. announced the repurchase of up to 1,500,000 Class II Preferred Shares for ¥6B, up to 301,000 2nd Series of Class VI Preferred Shares for ¥6.1B, and up to 4,723 2nd Series of Class VII Preferred Shares for ¥2.4B, as preparation for a joint share transfer with The Chiba Bank, Ltd. to establish Chiba Financial Group, Inc. effective April 1, 2027. Repurchases will occur via agreement with shareholders from July 1, 2026, to January 31, 2027, following the prior cancellation of 1st Series of Class VII Preferred Shares on April 1, 2026. The move aims to maintain a capital ratio of at least 8% post-transaction.

• ·Bank plans to secure capital ratio of at least 8% post-Share Transfer through Joint Holding Company support.
• ·Repurchase methods involve agreements with specific preferred shareholders, with notice or public announcement.
• ·Future Form F-4 filing planned with SEC for the Share Transfer.

25-03-2026

Zedge, Inc. announced a 25% increase in its quarterly cash dividend to $0.02 per share from $0.016, payable on April 15, 2026 to stockholders of record as of April 6, 2026, reflecting confidence in business prospects backed by record Q2 revenue, ARPMAU, active subscriptions, Zedge Premium GTV, and 31% YoY free cash flow growth. The company maintains a debt-free balance sheet with $19.1 million in cash. No declines or flat metrics were reported.

• ·Dividend initiated just five months prior to this increase.
• ·Company remains debt-free.

25-03-2026

Merck announced a definitive agreement to acquire Terns Pharmaceuticals for $53.00 per share in cash, valuing the equity at approximately $6.7B ($5.7B net of cash), a 31% premium to the 60-day VWAP and 42% to the 90-day VWAP as of March 24, 2026. The deal expands Merck's hematology pipeline with TERN-701, an investigational oral allosteric BCR::ABL1 TKI in Phase 1/2 for CML, expected to close in Q2 2026 subject to antitrust approval and tender offer conditions, resulting in a $5.8B charge ($2.35/share) to Merck's Q2 and FY2026 results. While promising early clinical data shows encouraging responses and low adverse events, the transaction carries risks including regulatory delays and shareholder litigation.

• ·Dose escalation of CARDINAL trial completed January 2025 with no dose-limiting toxicities up to 500mg QD.
• ·Dose expansion initiated April 2025 with 320mg or 500mg QD cohorts (up to 40 patients each).
• ·Additional CARDINAL cohort added January 2026 for BCR::ABL1 resistance mutations (e.g., T315I) in ~20 patients.
• ·FDA granted Orphan Drug Designation for TERN-701 in CML in March 2024.
• ·Merck investor call held March 25, 2026 at 8 a.m. EDT.
• ·Transaction via tender offer; merger agreement to be filed with SEC.

25-03-2026

Kiora Pharmaceuticals reported a full-year 2025 net loss of $10.8M, compared to net income of $3.6M in 2024, driven by the absence of $16M upfront collaboration revenue from Théa and higher R&D expenses of $10.8M (up 38% YoY before reimbursements). While R&D and G&A expenses increased (R&D Q4 up 53% to $2.9M, G&A FY up 4% to $5.7M), the company advanced KIO-301 and KIO-104 into active Phase 2 trials (ABACUS-2 and KLARITY) and ended 2025 with $17.1M in cash, cash equivalents, and short-term investments, providing a runway into late 2027. Pipeline momentum includes a Senju option agreement worth up to $110M plus royalties and potential KIO-300 expansion.

• ·Net cash used in operating activities: Q4 2025 $2.2M, FY 2025 $10.0M
• ·In-process R&D impairment: $4.6M in FY 2025
• ·Anticipated data readouts: ABACUS-2 in Q3 2027, KLARITY in H1 2027
• ·Total assets: $24.3M at Dec 31, 2025 vs $36.5M at Dec 31, 2024

25-03-2026

KalVista Pharmaceuticals reported $49.1 million in global net product revenue from EKTERLY for the eight months ended December 31, 2025, driven by strong US adoption with 1,702 patient start forms (nearly 20% of US HAE patients) and 724 unique prescribers through February 2026, alongside launches in Germany and Japan. However, SG&A expenses more than doubled to $124.7 million from $64.9 million in the prior eight-month period, contributing to an operating loss of $112.0 million and net loss of $109.5 million, though slightly improved from prior period losses. Cash and equivalents rose to $300.2 million from $220.6 million as of April 30, 2025, expected to fund operations through profitability.

• ·US EKTERLY launch initiated July 7, 2025; German launch ongoing with similar adoption trends.
• ·Completed enrollment in Phase 3 KONFIDENT-KID trial ahead of schedule; interim data at March 26-29, 2026 conference; US NDA filing planned Q3 2026 with 2027 launch.
• ·EKTERLY approved in US, EU, UK, Switzerland, Australia, Singapore, Japan for patients 12+; pediatric filing 2-11 years planned 2026.
• ·Stockholders' equity shifted to deficit of $2.7M as of Dec 31, 2025 from $95.4M surplus as of Apr 30, 2025.

25-03-2026

Cipher Digital Inc., a subsidiary of Cipher Mining Inc., entered into a senior secured revolving credit agreement dated March 23, 2026, with a lender syndicate led by Morgan Stanley Senior Funding, Inc. as Administrative Agent and Collateral Agent, and joint arrangers including Banco Santander, Goldman Sachs Lending Partners LLC, JPMorgan Chase Bank, N.A., Sumitomo Mitsui Banking Corporation, and Wells Fargo Securities, LLC. Proceeds are for working capital and general corporate purposes, with interest margins starting at Term SOFR +1.750% / ABR +0.750% (adjustable down to +1.250% / +0.250% based on Consolidated Total Debt to Market Capitalization Ratio <0.30x) and a 0.50% commitment fee; no facility size or drawdowns specified.

• ·Pricing grid based on Consolidated Total Debt to Market Capitalization Ratio: Level 1 (<0.30:1) 1.250%/0.250%; Level 2 (0.30-0.60:1) 1.500%/0.500%; Level 3 (>0.60:1) 1.750%/0.750% for Term SOFR/ABR.
• ·Initial pricing effective until Compliance Certificate for fiscal quarter ending September 30, 2026.
• ·Alternate Base Rate defined as highest of 1.00%, Prime Rate, Federal Funds Effective Rate + 0.50%, or Adjusted Term SOFR (1-month) + 1.00%.

25-03-2026

Apimeds Pharmaceuticals US, Inc. (APUS) filed an 8-K on March 25, 2026, disclosing the Second Amendment to its Bylaws dated March 20, 2026, under Items 5.02 (Director/Officer Departure/Election), 5.03 (Bylaws Amendment), 8.01, and 9.01. The amendments restate Section 17 to require Board vacancies to be filled solely by the affirmative vote of a majority of shares of capital stock entitled to vote at a stockholders' meeting or by written consent. Section 47 is restated to empower both the Board (by majority of authorized directors) and stockholders (by majority vote) to adopt, amend, or repeal the Bylaws.

• ·Filing Items: 5.02 (Director/Officer Departure/Election), 5.03 (Amendments to Bylaws), 8.01 (Other Events), 9.01 (Exhibits)

25-03-2026

Local Bounti reported robust FY2025 revenue growth of 27% YoY to $48.4M, with Q4 sales up 24% to $12.5M driven by increased production across Georgia, Texas, and Washington facilities; gross profit rose 43% FY and 182% in Q4, while net loss narrowed 21% FY to $94.4M and Adjusted EBITDA loss improved 12% to $28.3M. However, G&A expenses increased 3% FY to $33.8M due to a $3.7M intangible impairment, and the company remains unprofitable with ongoing Adjusted EBITDA losses. Post-year-end, it secured $15M from an existing strategic investor and received a key U.S. patent for AI-driven growing optimization.

• ·Adjusted gross margin reached 29% in both Q4 and FY2025.
• ·Q4 G&A reduced by $1.0M to $7.1M; adjusted G&A down 18% to $4.3M.
• ·Company reduced annualized expenses by nearly $10M in FY2025.
• ·U.S. Patent No. 12,557,741 issued Feb 2026 for AI growing optimization.
• ·Secured new retail accounts in Q1 2026: >250 stores with 6 SKUs and large regional retailer.
• ·Tower upgrades completed Q4 2025, boosting yield capacity 10%; CA investments targeting up to 20% yield improvement.

25-03-2026

Generac Holdings Inc. disclosed preliminary full-year 2025 financial results via Exhibit 99.1 in an 8-K filing, reporting net sales of $4.2B and Adjusted EBITDA of $716M for the twelve months ended December 31, 2025. The Residential segment led with $2.5B in net sales and $558M in Adjusted EBITDA, while the Commercial & Industrial segment contributed $1.8B in sales but a lower $200M in Adjusted EBITDA. Income before provision for income taxes totaled $199M after significant adjustments including $158M in legal/regulatory provisions and $71M in interest expense.

• ·Interest expense: $71M
• ·Depreciation and amortization: $195M
• ·Provision for legal, regulatory, and other costs: $158M
• ·Non-cash share-based compensation expense: $50M
• ·Change in fair value of investments: $21M

25-03-2026

Texas Community Bancshares, Inc. (TCBS) reported a profitable year in 2025 with net income of $2,842 thousand, reversing a $1,305 thousand loss in 2024, driven by higher net interest income of $13,314 thousand (up 6%) and positive noninterest income of $3,079 thousand versus a $1,903 thousand loss, alongside NIM expansion to 3.26%. However, total assets declined 3% to $429,842 thousand, deposits fell 2% to $327,904 thousand, and nonperforming assets surged 316% to $11,407 thousand or 2.65% of total assets from 0.62%, primarily due to foreclosures adding $9,271 thousand in other real estate owned. Loans grew 3% to $303,205 thousand net, with commercial real estate increasing to $61.5 million (20.1% of loans) from $56.1 million, while construction and land loans declined to $48.4 million (15.8%) from $54.1 million.

• ·Nonaccrual loans decreased to $2,014 thousand from $2,125 thousand.
• ·Provision for credit losses increased to $831 thousand from $158 thousand.
• ·Total capital to risk-weighted assets improved to 16.67% from 15.60%.
• ·Net charge-offs to average loans were -0.17% in 2025 versus -0.05% in 2024.
• ·Premises and equipment net book value: Main office $1,668 thousand; Lindale branch $4,062 thousand.

25-03-2026

The 10-K annual report for GS Mortgage Securities Trust 2013-GC13, filed on March 25, 2026, contains management's assertions and third-party reports on compliance with servicing criteria under Item 1122 of Regulation AB. Multiple tables detail which criteria (e.g., monitoring triggers, custodial accounts, fidelity bonds) are performed directly by the asserting party, via responsible vendors, by non-responsible parties, or deemed inapplicable/not performed, with several marked as 'NOT performed' including back-up servicer maintenance and certain cash administration tasks. No financial performance metrics, delinquencies, or changes are disclosed in the provided excerpts.

• ·Several servicing criteria, such as 1122(d)(1)(iii) (back-up servicer maintenance), are marked as NOT performed by the company, subservicers, or retained vendors.
• ·CoreLogic asserts direct performance for criteria including fidelity bonds (1122(d)(1)(iv)), wire disbursements (1122(d)(2)(ii)), and custodial accounts at federally insured institutions (1122(d)(2)(v)), but NOT performed for others like advances (1122(d)(2)(iii)) and account separation (1122(d)(2)(iv)).

25-03-2026

The Cato Corporation reported a narrowed Q4 FY2025 net loss of ($10.7) million or ($0.55) per diluted share compared to ($14.1) million or ($0.74) prior year, despite sales declining 3.4% to $150.0 million with flat same-store sales. Full-year FY2025 net loss improved to ($5.9) million or ($0.31) per diluted share from ($18.1) million or ($0.97), supported by 0.7% sales growth to $646.8 million and 4% same-store sales increase, alongside gross margin expansion to 33.3% and SG&A reduction to 35.0% of sales. However, the company closed 48 stores, reducing total to 1,069, and plans up to 40 more closures in 2026 amid tempered outlook due to economic uncertainties.

• ·Q4 SG&A expenses decreased $1.9 million to $56.8 million.
• ·FY SG&A expenses decreased $5.0 million to $226.5 million.
• ·Cash and equivalents $16.8 million as of Jan 31, 2026, down from $20.3 million.
• ·Plans to open up to 10 new stores and close up to 40 in 2026.

25-03-2026

Winnebago Industries reported net revenues of $657.4 million for the three months ended February 28, 2026, up 6.0% YoY from $620.2 million, with net income of $4.8 million versus a prior-year loss of $0.4 million; operating income rose 51.3% to $11.8 million. However, Towable RV segment revenues declined 9.0% to $262.4 million while Motorhome RV grew 29.4% to $304.7 million and Marine dipped 3.0% to $79.2 million. For the six months, revenues increased 9.2% to $1,360.1 million and net income turned positive at $10.3 million from a $5.6 million loss, though cash equivalents fell sharply to $47.4 million from $174.0 million.

• ·Long-term debt reduced to $442.3 million from $540.5 million at August 30, 2025.
• ·Net cash used in operating activities improved to $0.6 million from -$27.2 million for six months.
• ·Inventories increased to $407.6 million from $396.4 million.
• ·Common stock dividends declared at $0.35 per share for the quarter.

25-03-2026

ARMOUR Residential REIT, Inc. announced guidance for a monthly cash dividend of $0.24 per share on its common stock for April 2026. The dividend is payable on April 29, 2026 to holders of record as of April 15, 2026. A press release detailing the announcement is attached as Exhibit 99.1.

• ·Securities registered: Preferred Stock, 7.00% Series C Cumulative Redeemable (ARR-PRC), Common Stock $0.001 par value (ARR), both on New York Stock Exchange
• ·Filing signed by Gordon M. Harper on March 25, 2026

25-03-2026

Longeveron Inc. received a Nasdaq notice on March 24, 2026, granting an additional 180 days until September 21, 2026, to regain compliance with the $1.00 minimum bid price requirement after missing the initial 180-day deadline of March 23, 2026, stemming from an original deficiency notice on September 22, 2025. The company's Class A common stock listing on The Nasdaq Capital Market remains effective with no immediate impact. Management plans to monitor stock price and may pursue a reverse stock split, though success is not assured.

• ·Initial Nasdaq deficiency notice issued September 22, 2025, due to closing bid price below $1.00 for 30 consecutive business days.
• ·Compliance requires $1.00 closing bid price for at least 10 consecutive business days.
• ·Company classified as emerging growth company.

25-03-2026

For the twelve months ended December 31, 2025, Global Self Storage, Inc. reported revenues of $12,631,502, up 1.4% YoY, with net operating income increasing 0.6% to $7,767,100 and AFFO rising to $4,402,971 from $4,259,327; however, net income declined to $2,038,451 from $2,123,743, and Q4 revenues fell 0.9% to $3,140,574 with NOI down 4.1% to $1,903,543. Overall square foot occupancy improved slightly to 93.0% from 92.9%, but total assets decreased to $64,072,646 from $65,515,024. FFO per share increased to $0.36 from $0.35, while EPS dipped to $0.18 from $0.19.

• ·Depreciation and amortization remained flat at approximately $1.45M annually.
• ·Note payable decreased to $15,785,874 from $16,356,582.
• ·Weighted average diluted shares outstanding: 11,224,476 for 2025 vs 11,143,831 for 2024.
• ·Cash and cash equivalents increased to $7,364,963 from $7,180,857.

25-03-2026

Parke Bancorp, Inc. (PKBK) announced on March 25, 2026, the declaration of a cash dividend of $0.18 per share, payable on April 17, 2026, to shareholders of record as of the close of business on April 3, 2026. The announcement references a press release filed as Exhibit 99.1. No comparative financial metrics or performance data were provided in the filing.

• ·Securities registered: Common Stock, Par Value $0.10 per share (PKBK on The Nasdaq Stock Market, LLC)

25-03-2026

Armata Pharmaceuticals reported grant revenue of $4.9M for 2025, down 5.2% YoY from $5.2M, while operating expenses decreased 12.8% to $41.5M, driven by a 31.1% drop in R&D to $23.7M, resulting in a smaller operating loss of $36.6M (13.7% improvement). However, a $121.0M negative change in fair value of the Convertible Loan, coupled with higher interest expense up 54.4% to $16.6M, led to a sharply widened net loss of $173.8M (818.8% worse YoY) and stockholders' deficit ballooning to $218.6M from $48.0M.

• ·Cash, cash equivalents and restricted cash decreased to $14.1M from $14.8M YoY.
• ·Term debt increased to $103.1M non-current in 2025 from $22.5M.
• ·Impairment expense of $5.4M recognized in 2025 (none in 2024).
• ·Net loss per share basic $4.80 in 2025 vs $0.52 in 2024.
• ·Proceeds from term debt $25.0M in financing activities 2025.

25-03-2026

3M Company (MMM) filed Definitive Additional Materials (DEFA14A) on March 25, 2026, as a proxy statement pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing was made by the registrant with no fee required. No financial metrics, performance data, or specific proposals are detailed in the provided header content.

• ·Filing Type: DEFA14A (Schedule 14A)
• ·Subcategory: Proxy Statement Definitive Additional Materials
• ·Filed by the Registrant, no fee required

25-03-2026

Union Pacific Corp's DEF 14A Proxy Statement for the May 14, 2026 annual shareholder meeting seeks approval for the election of 11 director nominees, ratification of Deloitte & Touche LLP as the independent auditor for 2026, and an advisory vote on executive compensation, with the Board recommending FOR all proposals. The proxy highlights ongoing safety improvements through four pillars (Injury Prevention, Leveraging Technology, Situational Awareness Testing, Peer-to-Peer Engagement), supporting long-term freight volume growth, operational excellence, and service; no quantitative performance declines or flat metrics are disclosed. Record date is March 13, 2026, with virtual meeting access via webcast.

• ·Annual meeting: May 14, 2026, 8:00 A.M. CDT via live audio webcast at www.virtualshareholdermeeting.com/UNP2026
• ·Record date: March 13, 2026
• ·2025 Annual Report on Form 10-K filed February 6, 2026
• ·Voting methods: Internet (www.proxyvote.com), telephone (1-800-690-6903), mail

25-03-2026

Addentax Group Corp. (ATXG) dismissed Pan-China Singapore PAC (PCS) as its independent registered public accounting firm effective March 25, 2026, and appointed HML PLT for the fiscal year ending March 31, 2026. PCS's reports for fiscal years ended March 31, 2025 and 2024 were unqualified with no disagreements or reportable events noted. The Company provided PCS with this filing, and PCS's agreeing letter is attached as Exhibit 16.1.

• ·Company address: Kingkey 100, Block A, Room 4805, Luohu District, Shenzhen City, China 518000
• ·Telephone: +(86) 755 86961 405
• ·Common Stock traded as ATXG on Nasdaq Capital Market

25-03-2026

Barings Participation Investors (MPV) and Barings Corporate Investors (MCI) have issued a proxy statement for their joint virtual 2026 Annual Meeting of Shareholders on May 14, 2026, at 8:00 a.m. ET, seeking election of three Independent Trustees—Michael H. Brown, Barbara M. Ginader, and Maleyne M. Syracuse—each for a three-year term, with shareholders voting separately by Trust. Record date shareholders hold 20,555,752 shares for MCI and 10,773,235 shares for MPV. MassMutual is deemed a beneficial owner of more than 5% of each Trust's shares due to holding a $30,000,000 MCI convertible note and a $15,000,000 MPV convertible note.

• ·Record date: March 16, 2026
• ·Meeting held virtually only at https://www.viewproxy.com/barings/broadridgevsm/
• ·Board recommends voting FOR all three Trustee nominees
• ·No other matters expected to be presented
• ·MassMutual convertible notes based on average share price over ten business days prior to conversion notice

25-03-2026

The 10-K Annual Report for GS Mortgage Securities Trust 2015-GC30, filed on March 25, 2026, contains assertions from Midland and management regarding compliance with servicing criteria under Item 1122(d). Most criteria for general servicing considerations and cash collection/administration were marked as performed directly (X) or by responsible vendors, with minor instances noted as N/A (e.g., back-up servicer requirements) or inapplicable. The filing includes a schedule listing numerous SLM Student Loan Trusts, Navient trusts, Synchrony trusts, and others, indicating related securitized pools.

• ·Filing date: March 25, 2026
• ·Specific servicing criteria with N/A: 1122(d)(1)(iii) back-up servicer in some tables
• ·Criteria 1122(d)(2)(vi) unissued checks safeguarding appears only in one exhibit

25-03-2026

Southside Bancshares, Inc. (SBSI) filed a DEFA14A Definitive Additional Materials proxy statement on March 25, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. No fee was required for the filing. The document appears to be a proxy notice for 2026 with no additional financial or operational details provided.

• ·Filing Type: DEFA14A
• ·Subcategory: Proxy Statement

25-03-2026

Dolphin Entertainment reported FY2025 revenue of $56.7M, up 10% YoY from $51.7M, with Q4 revenue surging 27% YoY to $15.6M; Adjusted EBITDA more than tripled to $2.9M from $0.9M, and Q4 swung to $1.7M profit from a $0.5M loss. However, the company still posted a FY2025 net loss of $3.1M (improved from $12.6M in 2024) and a small operating loss of $0.04M, with basic EPS at $(0.27) versus $(1.22) prior year. Management expects continued revenue growth and EBITDA margin expansion in 2026, supported by debt reduction saving ~$2.2M annually and $1M in lease savings.

• ·Total assets $58.3M as of Dec 31, 2025, down slightly from $58.4M in 2024.
• ·Current liabilities increased to $28.5M from $26.5M YoY.
• ·Stockholders’ equity declined to $9.7M from $11.6M.
• ·Expected annualized savings: $2.2M from bank debt maturity, $1M from lease terminations.
• ·Conference call scheduled for March 25, 2026 at 4:30pm ET.

25-03-2026

On March 23, 2026, Jae A. Evans resigned from the Board of Directors of Isabella Bank Corporation and its subsidiary Isabella Bank, effective as of the close of business on that date. There is no disagreement, known to an executive officer of the Corporation, between the Corporation and Mr. Evans on any matter relating to the Corporation’s operations, policies, or practices. The 8-K filing was submitted on March 25, 2026.

25-03-2026

Banco Bradesco's 20-F annual report outlines a new regulatory approach to credit risk provisioning, extending its scope to loans, advances, and other financial assets. Provisions are calculated using expected loss models based on debtor characteristics, with Stage 1 covering 12-month expected losses for low-risk operations and Stage 2 for lifetime losses on higher-risk assets. BCB Resolution No. 352/23 introduces minimum provisions for arrears over 90 days, segmented by portfolio risk, alongside requirements for continuous model monitoring.

• ·BCB Resolution No. 352/23 applies minimum provision parameters based on portfolio risk, nature, and delinquent period.
• ·Filing date: March 25, 2026

25-03-2026

Gulf Coast Ultra Deep Royalty Trust reported total assets of $1,083,556 as of December 31, 2025, up 4.6% from $1,036,027 at year-end 2024, with operating cash rising 31% to $20,419 and reserve fund cash increasing 4.2% to $1,063,137. However, the trust corpus deficit widened 63% to ($547,702) from ($336,061), interest income declined 74% to $978, the note payable to HOGA doubled to $416,489, administrative expenses totaled $562,619 (down 37% YoY), and distributable income remained at $0 for the second year. Royalty trust units outstanding were flat at 230,172,696.

• ·Reserve fund liability increased to $1,214,769 as of Dec 31, 2025 from $1,172,088 as of Dec 31, 2024.
• ·Administrative expenses in excess of income improved to ($561,641) in 2025 from ($895,718) in 2024.

25-03-2026

BANK5's 10-K filing includes Appendix B, which details compliance with Regulation AB Rule 1122(d) servicing criteria across multiple servicers including the Company, Midland, Berkadia, and CoreLogic. The majority of criteria in areas such as general servicing considerations, cash collection, and pool asset administration are marked as performed directly by the servicer or by vendors for which they are responsible, while several investor remittances and reporting criteria (e.g., 1122(d)(3)(i)(B)-(D), (ii)-(iv)) are noted as not performed or N/A. No material deficiencies or exceptions are highlighted in the disclosures.

• ·Filing date: March 25, 2026
• ·Multiple criteria marked N/A or not performed, including back-up servicer maintenance (1122(d)(1)(iii)) and certain external enhancements (1122(d)(4)(xv))

25-03-2026

Calumet, Inc. (NASDAQ: CLMT) announced that Board member Jennifer Straumins will not seek re-election and retire at the end of her current term, expiring at the 2026 Annual Meeting of Stockholders. Straumins joined the Board in July 2024, previously served on Calumet GP, LLC's board from February 2021 to July 2024, and was an employee for 13 years, contributing to Strategy and Growth and Risk Committees. Leadership expressed gratitude for her contributions, with the Board to evaluate composition for strategic alignment.

• ·Headquartered in Indianapolis, Indiana; operates twelve facilities throughout North America.
• ·Investor contact: John Kompa (317-957-5237, John.Kompa@calumetspecialty.com).
• ·Public Relations contact: Media Oakes (317-957-5319, Media.Oakes@calumetspecialty.com).

25-03-2026

On March 19, 2026, the Boards of Directors of Orange County Bancorp, Inc. and its wholly owned subsidiary Orange Bank & Trust Company amended the employment agreement of President and CEO Michael J. Gilfeather, extending it through March 31, 2029, with no other changes. They also amended his Performance-Based Supplemental Executive Retirement Plan Participation Agreement to provide a discretionary $125,000 employer contribution for the 2028 Plan Year, which will cliff vest on March 30, 2029. The amendments will be filed as exhibits in the Company's Form 10-Q for the quarter ending March 31, 2026.

• ·Amendments executed on March 19, 2026; filing dated March 25, 2026